Rize Oncology Inc.
RZONF
$0.16
$0.1639,900.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.49% | -31.11% | 20.28% | -6.31% | -17.68% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.41% | 637.29% | -39.16% | -32.06% | 4,786.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.71% | -14.12% | 17.36% | -8.02% | -11.94% |
|
|
|||||
| Total Current Assets | -35.71% | -14.12% | 17.36% | -8.02% | -11.94% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -35.71% | -14.12% | 17.36% | -8.02% | -11.94% |
|
|
|||||
| Total Accounts Payable | -73.81% | -57.84% | 171.09% | 26.72% | -57.74% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -73.81% | -59.57% | 182.65% | 26.72% | -57.74% |
|
|
|||||
| Total Current Liabilities | -73.81% | -59.57% | 182.65% | 26.72% | -57.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -73.81% | -59.57% | 182.65% | 26.72% | -57.74% |
|
|
|||||
| Common Stock & APIC | 0.22% | 8.41% | 0.01% | 0.34% | 0.03% |
| Retained Earnings | -7.86% | -5.49% | -3.65% | -2.84% | -2.44% |
| Treasury Stock & Other | 17.77% | -397.81% | 142.33% | 6.34% | -5.94% |
| Total Common Equity | -34.41% | -10.72% | 12.44% | -8.77% | -9.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.41% | -10.72% | 12.44% | -8.77% | -9.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.41% | -10.72% | 12.44% | -8.77% | -9.84% |
|
|
|||||